International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totaling 39 shares, an increase of 21.9% from the December 31st total of 32 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 3,120 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 3,120 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.
International Stem Cell Price Performance
Shares of International Stem Cell stock traded down $0.02 during trading on Tuesday, hitting $0.14. The stock had a trading volume of 35,331 shares, compared to its average volume of 9,409. The business has a fifty day moving average of $0.14 and a two-hundred day moving average of $0.14. International Stem Cell has a fifty-two week low of $0.08 and a fifty-two week high of $0.27. The firm has a market cap of $1.12 million, a P/E ratio of -7.00 and a beta of 0.24.
International Stem Cell Company Profile
International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.
In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.
Further Reading
- Five stocks we like better than International Stem Cell
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Gold’s getting scarce.
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
